Pulmonary Hypertension Is Associated With Systemic Arterial Hypertension Among Patients With Normal Left Ventricular Diastolic Function

被引:8
作者
Itelman, Edward [1 ,2 ]
Segel, Michael J. [2 ,3 ]
Kuperstein, Rafael [2 ,4 ]
Feinberg, Micha [2 ,4 ]
Segev, Amit [2 ,4 ]
Segal, Gad [1 ,2 ]
Maor, Elad [2 ,4 ]
Grossman, Ehud [5 ]
机构
[1] Chaim Sheba Med Ctr, Internal Med Ward T, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Chaim Sheba Med Ctr, Dept Pulmonol, Ramat Gan, Israel
[4] Chaim Sheba Med Ctr, Leviev Heart Ctr, Ramat Gan, Israel
[5] Chaim Sheba Med Ctr, Internal Med Wing, Ramat Gan, Israel
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2021年 / 10卷 / 24期
关键词
diastolic dysfunction; pulmonary hypertension; systemic arterial hypertension; CONVERTING ENZYME 2; EUROPEAN ASSOCIATION; RECOMMENDATIONS; ACTIVATION; FAILURE; SOCIETY; UPDATE;
D O I
10.1161/JAHA.121.023603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The association of pulmonary and systemic arterial hypertension is believed to be mediated through hypertensive left heart disease. The purpose of the current study was to investigate whether pulmonary hypertension (PHT) is associated with systemic arterial hypertension among patients with apparently normal left ventricular diastolic function. Methods and Results Consecutive patients who had echocardiographic evaluation between 2007 and 2019 were enrolled. Patients with disease states that are known to be associated with PHT, including diastolic dysfunction, were excluded from the analysis. Estimated right ventricular systolic pressure was extracted for all patients from the echocardiographic reports. PHT was defined as estimated right ventricular systolic pressure >40 mm Hg. Multivariate logistic regression models were applied. Final study population included 25 916 patients with a median age of 59 (interquartile range, 44-69) years, of whom 12 501 (48%) were men and 13 265 (51%) had systemic arterial hypertension. Compared with normotensive patients, hypertensive patients were 3.2 times more likely to have PHT (95% CI, 2.91-3.53; P<0.001). A multivariate model adjusted for clinical and echocardiographic parameters that are known to be associated with PHT demonstrated that hypertensive patients are almost 3 times more likely to have PHT (95% CI, 2.45-3.15; P<0.001). The association was significant in multiple subgroups but was more significant among women compared with men (odds ratio, 3.1 versus 2.4; P for interaction <0.001). Conclusions PHT is associated with systemic arterial hypertension irrespective of left heart disease. The association is more pronounced among women.
引用
收藏
页数:23
相关论文
共 17 条
  • [1] 2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
    Baumgartner, Helmut
    Falk, Volkmar
    Bax, Jeroen J.
    De Bonis, Michele
    Hamm, Christian
    Holm, Per Johan
    Iung, Bernard
    Lancellotti, Patrizio
    Lansac, Emmanuel
    Rodriguez Munoz, Daniel
    Rosenhek, Raphael
    Sjogren, Johan
    Tornos Mas, Pilar
    Vahanian, Alec
    Walther, Thomas
    Wendler, Olaf
    Windecker, Stephan
    Luis Zamorano, Jose
    Windecker, Stephan
    Aboyans, Victor
    Agewall, Stefan
    Barbato, Emanuele
    Bueno, Hector
    Coca, Antonio
    Collet, Jean-Philippe
    Coman, Ioan Mircea
    Dean, Veronica
    Delgado, Victoria
    Fitzsimons, Donna
    Gaemperli, Oliver
    Hindricks, Gerhard
    Iung, Bernard
    Juni, Peter
    Katus, Hugo A.
    Knuuti, Juhani
    Lancellotti, Patrizio
    Leclercq, Christophe
    McDonagh, Theresa
    Piepoli, Massimo Francesco
    Ponikowski, Piotr
    Richter, Dimitrios J.
    Roffi, Marco
    Shlyakhto, Evgeny
    Simpson, Iain A.
    Zamorano, Jose Luis
    Kzhdryan, Hovhannes K.
    Mascherbauer, Julia
    Samadov, Fuad
    Shumavets, Vadim
    Van Camp, Guy
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (36) : 2739 - +
  • [2] Worldwide Trends in Prevalence, Mortality, and Disability-Adjusted Life Years for Hypertensive Heart Disease From 1990 to 2017
    Dai, Haijiang
    Bragazzi, Nicola Luigi
    Younis, Arwa
    Zhong, Wen
    Liu, Xinyao
    Wu, Jianhong
    Grossman, Ehud
    [J]. HYPERTENSION, 2021, 77 (04) : 1223 - 1233
  • [3] Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension
    Ferreira, Anderson J.
    Shenoy, Vinayak
    Yamazato, Yoriko
    Sriramula, Srinivas
    Francis, Joseph
    Yuan, Lihui
    Castellano, Ronald K.
    Ostrov, David A.
    Oh, Suk Paul
    Katovich, Michael J.
    Raizada, Mohan K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (11) : 1048 - 1054
  • [4] LEFT-VENTRICULAR FILLING AND STRESS RESPONSE PATTERN IN ESSENTIAL-HYPERTENSION
    GROSSMAN, E
    OREN, S
    MESSERLI, FH
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (05) : 502 - 506
  • [5] Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2/Angiotensin 1-7/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia
    Hampl, V.
    Herget, J.
    Bibova, J.
    Banasova, A.
    Huskova, Z.
    Vanourkova, Z.
    Jichova, S.
    Kujal, P.
    Vernerova, Z.
    Sadowski, J.
    Cervenka, L.
    [J]. PHYSIOLOGICAL RESEARCH, 2015, 64 (01) : 25 - 38
  • [6] PULMONARY ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND INFLAMMATORY LUNG DISEASE
    Jia, Hongpeng
    [J]. SHOCK, 2016, 46 (03): : 239 - 248
  • [7] Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats
    Kanno, S
    Wu, YJL
    Lee, PC
    Billiar, TR
    Ho, C
    [J]. CIRCULATION, 2001, 104 (08) : 945 - 950
  • [8] Recommendations for chamber quantification
    Lang, Roberto M.
    Bierig, Michelle
    Devereux, Richard B.
    Flachskampf, Frank A.
    Foster, Elyse
    Pellikka, Patricia A.
    Picard, Michael H.
    Roman, Mary J.
    Seward, James
    Shanewise, Jack
    Solomon, Scott
    Spencer, Kirk T.
    Sutton, Martin St. John
    Stewart, William
    [J]. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (02): : 79 - 108
  • [9] Larry Jameson J., 2018, HARRISONS PRINCIPLES, V1, P4048
  • [10] Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
    Meng, Ying
    Yu, Chang-Hui
    Li, Wei
    Li, Ting
    Luo, Wei
    Huang, Shan
    Wu, Ping-Sheng
    Cai, Shao-Xi
    Li, Xu
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 50 (04) : 723 - 736